Ads
related to: recent advances in osteoporosis medicine listexplorepanel.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
In May 2003, the US Food and Drug Administration (FDA) approved ibandronate as a daily treatment for post-menopausal osteoporosis. [medical citation needed] The basis for this approval was a three-year, randomized, double-blind, placebo-controlled trial women with post-menopausal osteoporosis.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
Chemical structure of bisphosphonates. Bisphosphonates are an important class of drugs originally commercialised in the mid to late 20th century. They are used for the treatment of osteoporosis and other bone disorders that cause bone fragility and diseases where bone resorption is excessive.
For premium support please call: 800-290-4726 more ways to reach us
A recent abstract presented at the annual meeting of the Radiological Society of North America suggested that levothyroxine use in people with typical hormone ranges could lead to lower bone mass ...
Romosozumab is used for osteoporosis to decrease the risk of fractures. [10] Two trials found that it reduced the rate of vertebral fracture. In one, there was a 73% lower risk of vertebral fracture after one year, and the benefit was maintained after a second year of taking denosumab.
Ads
related to: recent advances in osteoporosis medicine listexplorepanel.com has been visited by 10K+ users in the past month